Both in Surgical Instruments
ResMed vs DexCom
Over the past year RMD returned −17.8% and DXCM returned +30.4%; their daily moves had a correlation of 0.34.
RMD −17.8% DXCM +30.4%Growth of $1, one year, split-adjusted
| Metric | RMD | DXCM |
|---|---|---|
| Price | $222.83 | $86.64 |
| Market cap | $32.14B | $32.69B |
| Today | +0.33% | −0.05% |
| 1 month | −7.3% | −4.6% |
| 6 months | +1.3% | +40.0% |
| Year to date | −7.5% | +30.5% |
| 1 year | −17.6% | +29.1% |
| Revenue growth (YoY) | +8.6% | +13.1% |
| Gross margin | 59.4% | 63.4% |
| Net margin | 26.2% | 19.0% |
| P/E (TTM) | 21.1× | 32.7× |
| Price / sales | 5.7× | 6.6× |
| Net cash | $809.9M | $704.2M |
| Dividend yield | 1.18% | — |
| Volatility (60d) | 33.6% | 39.6% |
| Short % of float | 9.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).